Antibodies News and Research

RSS

Fred Hutch’s new Evergreen Fund to promote commercialization of research into lifesaving therapies

Fred Hutchinson Cancer Research Center announced its first-ever grants from its newly established Evergreen Fund to spur researchers' efforts to advance bold ideas toward creating or partnering with a commercial entity.

28 Dec 2016

Inherited CD70 deficiency increases susceptibility to Epstein-Barr virus and EBV-related cancer

Investigators at the National Institutes of Health and international colleagues have identified a genetic immune disorder characterized by increased susceptibility and poor immune control of Epstein-Barr virus (EBV) and, in some cases, an EBV-associated cancer called Hodgkin's lymphoma.

23 Dec 2016

Blocking protein that initiates immune response against viral infections may help combat HIV

In findings they call counterintuitive, a team of UCLA-led researchers suggests that blocking a protein, which is crucial to initiating the immune response against viral infections, may actually help combat HIV.

23 Dec 2016

Study discovers critical function of mother's immune cells in resisting preterm birth

Preterm birth -- birth before 37 weeks of pregnancy -- affects up to one in every six births in the United States and many other countries.

22 Dec 2016

TSRI scientists identify microbial natural products as abundant sources of potent anticancer drugs

Scientists from the Florida campus of The Scripps Research Institute have developed an efficient process to rapidly discover new “enediyne natural products” from soil microbes that could be further developed into extremely potent anticancer drugs.

22 Dec 2016

Scientists pinpoint specific molecular events that may cause allergic reactions to air pollution

Scientists at the Immunology Frontier Research Center at Osaka University, Japan have pinpointed a specific molecular events that could explain allergic reactions to air pollution.

22 Dec 2016

Biomarker for oxidative stress plays key role in development of NAFLD, study shows

Diet-related diseases like non-alcoholic fatty liver disease (NAFLD) are known to have a major inflammatory component.

21 Dec 2016

Researchers engineer promising live-attenuated RSV vaccine candidate

Crafting a vaccine against RSV (respiratory syncytial virus) has been a minefield for 50 years, but scientists believe they have found the right balance.

21 Dec 2016

Leading journal publishes article about ciliate lipases as therapeutic candidates for oral treatment of EPI

Cilian AG, a biopharmaceutical company focused on the development of subunit vaccines, enzymes and monoclonal antibodies, announces that the European Journal of Gastroenterology & Hepatology, the international, peer-reviewed, online publication journal, has published an article entitled: Novel ciliate lipases for enzyme replacement during exocrine pancreatic insufficiency.

20 Dec 2016

Scientists develop safe, effective vaccine for chikungunya fever from insect-specific virus

Researchers from The University of Texas Medical Branch at Galveston have developed the first vaccine for chikungunya fever made from an insect-specific virus that doesn't have any effect on people, making the vaccine safe and effective.

20 Dec 2016

Scientists develop novel nanoparticle-based method to deliver DNA vaccine

Scientists at Brigham and Women's Hospital have developed a novel method for delivering therapeutic molecules into cells.

20 Dec 2016

New review highlights need to reassess use of biologics for treating rheumatoid arthritis patients

The use of biologics, which are generally made from human and/or animal materials, has significantly changed the management of rheumatoid arthritis over the last decade, becoming the cornerstone treatment for many patients.

19 Dec 2016

Study addresses cost-effectiveness of checkpoint inhibitors for advanced melanoma in Hong Kong

Immunotherapy with pembrolizumab has been deemed a cost-effective first line treatment for advanced melanoma patients in Hong Kong, researchers report at the ESMO Asia 2016 Congress in Singapore.

17 Dec 2016

Scientists discover how COPD patients' lungs lose ability to repair damages

In chronic obstructive pulmonary disease (COPD), the patients' lungs lose their ability to repair damages on their own.

16 Dec 2016

Researchers develop promising therapeutic antibodies against tumor-promoting MMPs

Researchers at the University of California, Riverside have camels and llamas to thank for their development of a new cancer treatment that is highly selective in blocking the action of faulty matrix metalloproteinases (MMPs).

16 Dec 2016

Study suggests potential blood-based marker to predict oropharyngeal cancer recurrence

A new study suggests the possibility of predicting at its earliest stages when a type of head and neck cancer will come back.

16 Dec 2016

DuPont research project aims to enable global access for protein-based biologic medications

DuPont Industrial Biosciences today announced receipt of a grant from the Bill & Melinda Gates Foundation to support a new area of research. The research project, which commences immediately, aims to create new production systems to enable affordable, protein-based biologic medications, such as antibodies.

16 Dec 2016

WPI researchers develop chip to trap and identify metastatic cancer cells in blood

A chip developed by mechanical engineers at Worcester Polytechnic Institute can trap and identify metastatic cancer cells in a small amount of blood drawn from a cancer patient.

16 Dec 2016

Common bacterium that causes gum infections may trigger rheumatoid arthritis

Investigators at Johns Hopkins report they have new evidence that a bacterium known to cause chronic inflammatory gum infections also triggers the inflammatory "autoimmune" response characteristic of chronic, joint-destroying rheumatoid arthritis (RA).

15 Dec 2016

Researchers show how common bacterium in improperly cooked chicken triggers GBS

A Michigan State University research team is the first to show how a common bacterium found in improperly cooked chicken causes Guillain-Barre Syndrome, or GBS.

9 Dec 2016

Antibodies News and Research

Fred Hutch’s new Evergreen Fund to promote commercialization of research into lifesaving therapies

Inherited CD70 deficiency increases susceptibility to Epstein-Barr virus and EBV-related cancer

Blocking protein that initiates immune response against viral infections may help combat HIV

Study discovers critical function of mother's immune cells in resisting preterm birth

TSRI scientists identify microbial natural products as abundant sources of potent anticancer drugs

Scientists pinpoint specific molecular events that may cause allergic reactions to air pollution

Biomarker for oxidative stress plays key role in development of NAFLD, study shows

Researchers engineer promising live-attenuated RSV vaccine candidate

Leading journal publishes article about ciliate lipases as therapeutic candidates for oral treatment of EPI

Scientists develop safe, effective vaccine for chikungunya fever from insect-specific virus

Scientists develop novel nanoparticle-based method to deliver DNA vaccine

New review highlights need to reassess use of biologics for treating rheumatoid arthritis patients

Study addresses cost-effectiveness of checkpoint inhibitors for advanced melanoma in Hong Kong

Scientists discover how COPD patients' lungs lose ability to repair damages

Researchers develop promising therapeutic antibodies against tumor-promoting MMPs

Study suggests potential blood-based marker to predict oropharyngeal cancer recurrence

DuPont research project aims to enable global access for protein-based biologic medications

WPI researchers develop chip to trap and identify metastatic cancer cells in blood

Common bacterium that causes gum infections may trigger rheumatoid arthritis

Researchers show how common bacterium in improperly cooked chicken triggers GBS

eBook: End-to-end solutions for bispecific antibody development eBook

Latest eBooks

Industry Focus eBook - Analytical Chemistry (3rd edition)

Industry Focus eBook - Microbiome (1st edition)

Industry Focus eBook - Cell biology (5th edition)

Advancing degrader and proximity-based drug development

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo